Chairs
Emily Breidbart
Neha Patel
BOD Liaison
Laurie Cohen
Charged with keeping the Society informed on topics about both new and existing drugs and devices. To review problems related to the therapeutics of Pediatric Endocrine disorders and report to the Board of Directors and the greater membership of PES.
US FDA-approval of VAMOROLONE for Duchenne Muscular Dystrophy (DMD)*-a novel alternative steroid with unique properties
February 21, 2024
US FDA-approval of VAMOROLONE for Duchenne Muscular Dystrophy (DMD)*-a novel…
LUPRON DEPOT-PED 45 mg for 6 months
January 31, 2024
LUPRON DEPOT-PED 45 mg for 6 months Prepared and edited…